SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 27 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $25,000 | -92.8% | 76,896 | -88.8% | 0.01% | -89.6% |
Q4 2019 | $348,000 | -8.2% | 687,304 | -17.7% | 0.10% | -52.9% |
Q3 2019 | $379,000 | -23.7% | 835,459 | -7.6% | 0.20% | -67.4% |
Q2 2019 | $497,000 | +6.9% | 903,741 | +31.9% | 0.62% | +180.3% |
Q1 2019 | $465,000 | -25.7% | 684,926 | -38.7% | 0.22% | +61.6% |
Q4 2018 | $626,000 | – | 1,117,459 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 306,479 | $87,000 | 0.01% |
1620 INVESTMENT ADVISORS, INC. | 15,000 | $4,000 | 0.00% |
Landmark Financial Advisors, LLC | 24,200 | $6,000 | 0.00% |
MSD Partners, L.P. | 116,430 | $33,000 | 0.00% |
IFP Advisors, Inc | 17,650 | $58,000 | 0.00% |
Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
Focused Wealth Management, Inc | 500 | $0 | 0.00% |
JANE STREET GROUP, LLC | 281,700 | $80,000 | 0.00% |
UBS Group AG | 79,851 | $23,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1 | $0 | 0.00% |